Immunotherapy in Pediatric Solid Tumors
The survival rates for pediatric patients with solid tumors have improved dramatically in recent decades. However, patients with metastatic disease at diagnosis or progressive solid tumors still have a poor prognosis. Recently, immunotherapy has emerged as a novel therapeutic strategy in the pediatr...
Saved in:
Main Author: | Jung Yoon Choi (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Pediatric Hematology-Oncology,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recent updates on Sintilimab in solid tumor immunotherapy
by: Xuhong Liu, et al.
Published: (2020) -
Dendritic Cell-based Immunotherapy in Solid and Haematologic Tumors
Published: (2020) -
Self-Tumor Antigens in Solid Tumors Turned into Vaccines by α-gal Micelle Immunotherapy
by: Uri Galili
Published: (2024) -
CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond
by: Jialin Lu, et al.
Published: (2024) -
Pulmonary Metastasectomy in Pediatric Solid Tumors
by: Nicole J. Croteau, et al.
Published: (2019)